ABC Comments on Bacterial Risk Detection Draft Guidance

March 11, 2019
Read More

ABC Submits Comments on Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion Draft Guidance

March 8, 2019

In April 2017, we provided comments to the FDA including additional important information intended to reinforce positions stated in our May 2016 comments. This information was intended to identify specific critical concerns important to both blood collection establishments and transfusion services and to alert FDA to adverse, unintended consequences expected to impact the blood supply…

Read More

ABC, AABB, and the American Red Cross Joint Letter Requesting that the Centers for Medicare and Medicaid Services (CMS) Create “miscellaneous/not otherwise classified” HCPCS II Code for Blood Products as Part of the HCPCS 2020 Annual Update

January 4, 2019

ABC, AABB and the American Red Cross joint letter requesting that the Centers for Medicare and Medicaid Services (CMS) create “miscellaneous/not otherwise classified” HCPCS II code for blood products as part the HCPCS 2020 annual update.

Read More

AABB, America’s Blood Centers, the American Red Cross Encourage Congress to Pass PAHPAI

December 7, 2018

AABB (formerly known as the American Association of Blood Banks), America’s Blood Centers and the American Red Cross encourage you to pass the Pandemic and All-Hazards Preparedness & Advancing Innovation Act (PAHPAI, S. 2852 and H.R. 6378) before Congress adjourns for 2018. Collectively, our organizations represent the nation’s blood collection establishments, transfusion services, and transfusion…

Read More

December 2018 Medical Device Tax Repeal Coalition Letter

December 5, 2018

There are millions of Americans who struggle to manage complex, chronic and rare diseases. They, as well as their families and caregivers, rely on medical technology to not only save and extend lives, but also improve quality of life. On their behalf, the undersigned patient advocacy, disability, research, community, and healthcare industry organizations are writing…

Read More

AABB, ABC, ARC Provide Feedback on ASPR National Health Security Framework

October 26, 2018

AABB (formerly known as the American Association of Blood Banks), America’s Blood Centers and the American Red Cross appreciate the opportunity to provide feedback regarding the Assistant Secretary for Preparedness and Response’s (ASPR’s) four pillars to achieving national health security. Collectively, our organizations represent the nation’s blood collection establishments, transfusion services, and transfusion medicine professionals.

Read More

Joint Statement Regarding Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Proposed Rule (CMS-1695-P)

September 24, 2018

AABB, America’s Blood Centers and the American Red Cross welcome the opportunity to submit comments to the Centers for Medicare & Medicaid Services (CMS) in response to the proposed rule related to the hospital outpatient prospective payment system (OPPS) that was published in the Federal Register on July 31, 2018. Collectively, our organizations represent the…

Read More

A Joint Perspective on Tolerable Risk in Blood Safety

September 13, 2018

I am presenting the following perspective on behalf of AABB, America’s Blood Centers and the American Red Cross. Collectively, our organizations represent the nation’s blood collection establishments, transfusion services, and transfusion medicine professionals. We commend the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) for convening this meeting to explore the definition of…

Read More

Joint Statement to the Food and Drug Administration’s Blood Product Advisory Committee – Strategies to Control the Risk of Bacterial Contamination in Platelets for Transfusion

July 19, 2018

The AABB, America’s Blood Centers (ABC) and the American Red Cross (ARC) appreciate the opportunity to present this joint statement as the Food and Drug Administration (FDA) finalizes recommendations for bacterial risk control strategies for platelet transfusion.

Read More

Joint Response to CMS-1694-P: Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2019 Rates

June 14, 2018

Thank you for the opportunity to provide our comments on the proposed rule entitled, “Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2019 Rates” (Proposed Rule). We urge CMS to immediately address the critical underfunding of certain…

Read More

Search